Michael Iskra, Executive Vice President and Chief Commercial Officer of QuidelOrtho Corporation, leads the development and implementation of the company’s integrated global commercial strategy for accelerated growth.

Mr. Iskra has over a decade of global executive leadership experience and more than 30 years in the diagnostics and healthcare products and services industries. He holds significant knowledge and expertise across strategy, sales, marketing, operations and general management. 

Mr. Iskra was the Executive Vice President of Commercial Excellence and Strategy at Ortho Clinical Diagnostics from 2020 to 2022. Before assuming the role, Mr. Iskra was Ortho’s President of North America commercial operations, leading the company’s North America customer-facing organization, spanning sales, service and regional marketing, as well as regional commercial support functions.  

Prior to Ortho, he served as Senior Vice President of Business Development for Healthways. He previously was the CEO of Simplex Healthcare, general manager of CCS Medical and spent 14 years at Bayer/Siemens Diagnostics in a variety of roles, including head of marketing in Europe, with increasing responsibility. 

Mr. Iskra holds a B.A. in International Relations from the University of Delaware. He also completed the Executive Management Program at the University of Notre Dame, Mendoza College of Business, and the General Management Leadership Program at Columbia Business School.